EZH2 and breast carcinoma: For EZH2, 4 metastases were negative, 59 were weakly positive, and 38 were strongly positive; in reference, on the primary breast carcinoma array, 24 carcinomas were negative, 159 were weakly positive, and 35 were strongly positive.